MajorClass III antiarrhythmics (Vaughan Williams)×Selective beta-adrenergic blockers
Updated · Methodology
Mechanism
Both drugs slow the heart rate and cardiac conduction. Bisoprolol is a selective beta-blocker (bisoprolol SmPC). Amiodarone blocks alpha and beta adrenoceptors non-competitively and slows conduction through the sinus and atrioventricular nodes (amiodarone SmPC). Together they increase bradycardia and conduction disorders (both SmPCs). Amiodarone is eliminated over months, so the interaction can persist for several months after it is stopped (amiodarone SmPC).
Symptoms
Marked bradycardia, dizziness, weakness, fainting. On the ECG: atrioventricular block of varying degree, sinoatrial block, and rarely sinus arrest. In older patients the heart rate can fall especially sharply (amiodarone SmPC).
Management
The amiodarone SmPC does not recommend combining it with beta-blockers because of the risk of marked bradycardia and conduction disorders. The bisoprolol SmPC lists the combination with amiodarone as one to use with caution. If a cardiologist still prescribes both, monitor the heart rate (US Food and Drug Administration (FDA) amiodarone label). Before amiodarone is started, record an ECG and check serum potassium (amiodarone SmPC). Stop amiodarone if second- or third-degree atrioventricular block, sinoatrial block or bifascicular block develops (amiodarone SmPC). In older patients the heart rate can fall especially sharply. The interaction can persist for several months after amiodarone is stopped, so keep checking the heart rate after that too (amiodarone SmPC).
Check the full regimen, not just this pair
Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.
Summary of a multi-drug list →
Medicine list: everything you take in one place →
Sources
- FDA: Pacerone (amiodarone hydrochloride) tablets – Prescribing Information (2025)– FDA, DailyMed SPL, Upsher-Smith Laboratories, раздел 7
- AEMPS: Ficha técnica Trangorex 200 mg comprimidos (amiodarona) (2022)– AEMPS, CIMA, nº registro 48048, revisión 01/2022, sección 4.5
- AEMPS: Ficha técnica: Bisoprolol (nº registro 78903), sección 4.5 (2026)– AEMPS, CIMA, nº registro 78903, revisión 05/2026, sección 4.5